HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AL-34662: a potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist.

AbstractPURPOSE AND METHODS:
The aim of this study was to determine the ocular pharmacological characteristics of AL-34662 (1-((S)-2-aminopropyl)-1H-indazole-6-ol), a new synthetic serotonin-2 (5-HT2) receptor-agonist ocular hypotensive agent. A variety of well-documented in vitro and in vivo procedures were utilized to study the pharmacological attributes of AL-34662.
RESULTS:
AL-34662 exhibited a high affinity for the rat and human 5-HT2 receptor (IC50=0.8-1.5 nM) and for cloned human 5-HT2A-C receptors (IC50=3-14.5 nM). AL-34662 stimulated phosphoinositide turnover in human ciliary muscle (h-CM; EC50=289+/-80 nM) and in human trabecular meshwork (h-TM; EC50=254+/-50 nM) cells. AL-34662 also mobilized intracellular Ca2+ ([Ca2+]i) in h-CM (EC50=140+/-23 nM) and h-TM (EC50=38+/-8 nM) cells, being a full agonist like 5-HT itself. AL-34662's effects in the h-CM (and h-TM) cells were potently antagonized by 5-HT2A-antagonist M-100907 (IC50=1.8+/-0.7 nM), but weakly by 5-HT2B-antagonist (RS-127445 IC50>10 microM), 5-HT2B/C- antagonist (SB-242084 IC50=2.08 microM) and 5-HT2C antagonist (RS-102221 IC50>1 microM). AL-34662 caused relatively minimal ocular discomfort and hyperemia in rabbit and guinea pig eyes. It efficaciously lowered intraocular pressure (IOP) in the conscious ocular hypertensive monkey eyes (33% at 300 microg). The (R)-enantiomer (AL-34707) and the racemate (AL-34497) were less potent and/or efficacious than AL-34662 in all of these assays.
CONCLUSIONS:
AL-34662 is a high-affinity 5-HT2 receptor agonist that potently mobilizes [Ca2+]i in h-CM and h-TM cells, and which efficaciously lowers IOP in conscious ocular hypertensive cynomolgus monkey eyes through a local effect with minimal side-effects.
AuthorsNajam A Sharif, Marsha A McLaughlin, Curtis R Kelly
JournalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (J Ocul Pharmacol Ther) Vol. 23 Issue 1 Pg. 1-13 (Feb 2007) ISSN: 1080-7683 [Print] United States
PMID17341144 (Publication Type: Journal Article)
Chemical References
  • 1-(2-aminopropyl)-1H-indazole-6-ol
  • Antihypertensive Agents
  • Indazoles
  • Ligands
  • Phosphatidylinositols
  • Serotonin 5-HT2 Receptor Agonists
  • Calcium
Topics
  • Animals
  • Antihypertensive Agents (pharmacology, toxicity)
  • CHO Cells (drug effects)
  • Calcium (metabolism)
  • Cells, Cultured
  • Ciliary Body (drug effects, metabolism)
  • Cricetinae
  • Cricetulus
  • Drug Evaluation, Preclinical
  • Female
  • Guinea Pigs
  • Humans
  • Hyperemia (chemically induced)
  • Indazoles (chemistry, pharmacology)
  • Intraocular Pressure (drug effects)
  • Ligands
  • Macaca fascicularis
  • Muscle, Smooth (drug effects, metabolism)
  • Ocular Hypotension (drug therapy)
  • Phosphatidylinositols (metabolism)
  • Rabbits
  • Rats
  • Serotonin 5-HT2 Receptor Agonists
  • Trabecular Meshwork (drug effects, metabolism)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: